Header Logo

Connection

MEGHANA TRIVEDI to Neoplasms, Hormone-Dependent

Back to Details
This is a "connection" page, showing publications MEGHANA TRIVEDI has written about Neoplasms, Hormone-Dependent.
MEGHANA TRIVEDI
Connection Strength
0.149
Neoplasms, Hormone-Dependent
  1. The oral selective oestrogen receptor degrader (SERD) AZD9496 is comparable to fulvestrant in antagonising ER and circumventing endocrine resistance. Br J Cancer. 2019 02; 120(3):331-339.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.